論文

査読有り 招待有り
2018年2月1日

Zinc, carnosine, and neurodegenerative diseases

Nutrients
  • Masahiro Kawahara
  • ,
  • Ken-Ichiro Tanaka
  • ,
  • Midori Kato-Negishi

10
2
開始ページ
E147
終了ページ
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.3390/nu10020147
出版者・発行元
MDPI AG

Zinc (Zn) is abundantly present in the brain, and accumulates in the synaptic vesicles. Synaptic Zn is released with neuronal excitation, and plays essential roles in learning and memory. Increasing evidence suggests that the disruption of Zn homeostasis is involved in various neurodegenerative diseases including Alzheimer’s disease, a vascular type of dementia, and prion diseases. Our and other numerous studies suggest that carnosine (β-alanyl histidine) is protective against these neurodegenerative diseases. Carnosine is an endogenous dipeptide abundantly present in the skeletal muscles and in the brain, and has numerous beneficial effects such as antioxidant, metal chelating, anti-crosslinking, and anti-glycation activities. The complex of carnosine and Zn, termed polaprezinc, is widely used for Zn supplementation therapy and for the treatment of ulcers. Here, we review the link between Zn and these neurodegenerative diseases, and focus on the neuroprotective effects of carnosine. We also discuss the carnosine level in various foodstuffs and beneficial effects of dietary supplementation of carnosine.

リンク情報
DOI
https://doi.org/10.3390/nu10020147
ID情報
  • DOI : 10.3390/nu10020147
  • ISSN : 2072-6643
  • SCOPUS ID : 85041374103

エクスポート
BibTeX RIS